Summary:
- The article discusses a new gene therapy approach that has shown promise in treating a rare genetic disorder called spinal muscular atrophy (SMA).
- The gene therapy involves delivering a functional copy of the SMN1 gene, which is defective in individuals with SMA, using a viral vector.
- The treatment has demonstrated significant improvements in motor function and survival in infants with SMA, offering a potential long-term solution for this debilitating disease.